A new program proposed by the Centers for Medicare & Medicaid Services (CMS) would allow breakthrough medical devices to secure Medicare reimbursement.
The Transitional Coverage for Emerging Technologies pathway would expedite coverage for up to five devices each year.
Researchers have developed a new method to improve the treatment of epilepsy using focused ultrasound.
The technology increased the effectiveness of an anti-epilepsy drug by blocking the drug from binding to a protein that inhibits it from entering the brain.
The preclinical experiments produced fewer seizures and shorter duration of seizure activity.
“We are proud to share how far the field has come in recent years, and we realize that this remarkable progress is only possible through the hard work, time, and resources of everyone in our community.”
‒ Emily White, MD, on the 2023 State of the Field Report
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
By using FUSF’s AI agent, you acknowledge and agree that your use is governed by FUSF’s Terms of Use Agreement. If you do not agree to be bound by the Terms of Use Agreement, you may not access or use FUSF’s AI agent.
